⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

October 4, 2024Drug and Alcohol ReviewOpen Access

Vaping to quit smoking: Qualitative study of people receiving opioid agonist treatment

Kypros Kypri E. Austin Melissa A. Jackson Kirsten M. Wright Amanda Shui Andrew A. Li Vinogi Sathasivam Billie Bonevski Adrian Dunlop

View Full Paper

Ask AI

Bookmark

Share

Abstract

Most patients receiving opioid agonist treatment (OAT) smoke tobacco. Approved cessation interventions are less effective in this group than the wider population. We investigated how people on OAT experience nicotine vaping to quit smoking.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Kypri et al. (2024) studied this question.

synapsesocial.com/papers/68e55c8ae2b3180350efa29e https://doi.org/10.1111/dar.13953

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1HARMONY (HARM reduction for Opiates, Nicotine and You) Trial: Protocol of a Randomised Controlled Trial of the Effectiveness of Vaporised Nicotine Products for Tobacco Smoking Cessation amongst NSW Opiate Agonist Treatment Clients2024
2Addressing tobacco use in the context of opioid use disorder: A systematic review of smoking cessation interventions.Systematic Review · 2026
3Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities.cohort · 2020 · 13 citations
4Electronic cigarettes as a harm reduction strategy for combustible cigarette smoking among people in opioid use disorder treatment programs: protocol for an open-label two-arm randomized controlled trialRandomized Controlled Trial · 2026
5A qualitative study of using nicotine products for smoking cessation after discharge from residential drug and alcohol treatment in Australia2024 · 2 citations